A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery

Not Applicable

Completed

• Conditions: Surgery; Pain
• Interventions: Drug: .9 normal saline; Drug: 25 mg diphenhydramine IV; Drug: 50 mg diphenhydramine IV

• Registration Number: NCT01451762
• Lead Sponsor: Northwestern University

Brief Summary

Pain after ambulatory surgery remains an unsolved problem in The United States and Europe. It is associated with delayed hospital discharge and it can result to an increased opioid consumption with adverse side effects. The concept of multimodal analgesic technique was introduced more than 15 years ago and several techniques have been studied over the years including non steroidal antiinflammatory drugs (NSAIDs), acetaminophen, gabapentoids, ketamine, local and regional anesthetic techniques. Histamine can have effects on polymodal nociceptors and C-fibers, producing pain which is further increased by neurogenically mediated release of substance P from afferent pain fibers. Several non-selective or H1 -selective histamine receptors antagonists have been demonstrated in animal models and clinical pain. Chia et al demonstrated that preoperative promethazine had opioid sparing properties without adverse sedative effects in patients undergoing abdominal hysterectomy.

Diphenhydramine is an anti-histamine drug who has been found to be effective in reducing postoperative nausea and vomiting after ambulatory surgery but its effects on postoperative pain and other important outcomes after ambulatory surgery such as time to meet discharge criteria have not being studied.

The MQOR 40 is a validated instrument that was specifically design to evaluate patient recovery after anesthesia and surgery. This instrument can be particularly valid to examine interventions which affect different spheres of patient recovery as is the case of diphenhydramine. The objective of this study is to determine a dose response effect of preoperative diphenhydramine on postoperative quality of recovery after ambulatory surgery. The use of preoperative diphenhydramine can improve patient's quality of recovery, decrease postoperative pain, opioid consumption and opioid related side effects after ambulatory surgery.

The research question: Does a preoperative dose of diphenhydramine improve postoperative quality of recovery after ambulatory surgery? The hypothesis of this study is that preoperative diphenhydramine will improve postoperative pain, Postoperative nausea and vomiting (PONV), sleep which will translate in a better overall quality of recovery.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2011-09-20
• Study First Submitted QC: 2011-10-11
• Study First Posted: 2011-10-14
• Primary Completion: 2012-09
• Study Completion: 2012-09
• Results First Submitted: 2013-10-28
• Status Verified: 2014-02
• Results First Submitted QC: 2014-02-14
• Last Update Submitted: 2014-02-14
• Results First Posted: 2014-03-14
• Last Update Posted: 2014-03-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

• Age 18-64 years
• Patients undergoing ambulatory surgery
• ASA PS I, II.

Read More

Exclusion Criteria

• Chronic opioid use
• pregnant patient or lactating patients
• allergy to diphenhydramine
• glaucoma
• uncontrolled hypertension
• asthma
• hyperthyroidism
• cardiovascular disease

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	.9 normal saline	.9 normal saline IV
25 mg diphenhydramine IV	25 mg diphenhydramine IV	25 mg diphenhydramine IV administered before surgery
50 mg diphenhydramine IV	50 mg diphenhydramine IV	50 mg diphenhydramine IV administered before surgery

Primary Outcome Measures

Name	Time	Method
Quality of Recovery 40 at 24 Hours	24 hours post operatively	Scores on QOR (quality of recovery) 40 questionnaire.The QoR-40 score, which ranges from 40 to 200, representing very poor to outstanding quality of recovery, respectively.

Trial Locations

Locations (2)

Prentice Womens HOspital; 🇺🇸 Chicago, Illinois, United States

Prentice Womens HOsptial; 🇺🇸 Chicago, Illinois, United States